vs
Cronos Group Inc.（CRON）与FITLIFE BRANDS, INC.（FTLF）财务数据对比。点击上方公司名可切换其他公司
Cronos Group Inc.的季度营收约是FITLIFE BRANDS, INC.的1.7倍（$44.5M vs $25.9M）。FITLIFE BRANDS, INC.净利率更高（6.3% vs -4.1%，领先10.4%）。FITLIFE BRANDS, INC.同比增速更快（72.6% vs 47.0%）。Cronos Group Inc.自由现金流更多（$9.7M vs $239.0K）。过去两年Cronos Group Inc.的营收复合增速更高（32.7% vs 25.1%）
Cronos集团是全球性大麻素企业，主营大麻种植、加工及相关衍生产品的分销业务，产品线覆盖健康补充剂、快消品及医用大麻品类，主要服务北美、欧洲、亚太地区的合规娱乐与医用消费市场，严格遵循各地监管要求保障产品品质。
FitLife Brands, Inc.是一家健康保健企业，主营营养补充剂、运动营养产品及体重管理解决方案的研发、营销与分销，通过零售及电商渠道服务北美地区的健身爱好者、运动员及健康意识较强的消费群体。
CRON vs FTLF — 直观对比
营收规模更大
CRON
是对方的1.7倍
$25.9M
营收增速更快
FTLF
高出25.6%
47.0%
净利率更高
FTLF
高出10.4%
-4.1%
自由现金流更多
CRON
多$9.5M
$239.0K
两年增速更快
CRON
近两年复合增速
25.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $44.5M | $25.9M |
| 净利润 | $-1.8M | $1.6M |
| 毛利率 | 36.4% | 34.5% |
| 营业利润率 | -16.8% | 8.8% |
| 净利率 | -4.1% | 6.3% |
| 营收同比 | 47.0% | 72.6% |
| 净利润同比 | -104.2% | -20.8% |
| 每股收益（稀释后） | $-0.01 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRONFTLF
| Q4 25 | $44.5M | $25.9M | ||
| Q3 25 | $36.3M | $23.5M | ||
| Q2 25 | $33.5M | $16.1M | ||
| Q1 25 | $32.3M | $15.9M | ||
| Q4 24 | $30.3M | $15.0M | ||
| Q3 24 | $34.3M | $16.0M | ||
| Q2 24 | $27.8M | $16.9M | ||
| Q1 24 | $25.3M | $16.5M |
净利润CRONFTLF
| Q4 25 | $-1.8M | $1.6M | ||
| Q3 25 | $26.0M | $921.0K | ||
| Q2 25 | $-39.7M | $1.7M | ||
| Q1 25 | $6.1M | $2.0M | ||
| Q4 24 | $43.7M | $2.1M | ||
| Q3 24 | $8.3M | $2.1M | ||
| Q2 24 | $-8.8M | $2.6M | ||
| Q1 24 | $-2.2M | $2.2M |
毛利率CRONFTLF
| Q4 25 | 36.4% | 34.5% | ||
| Q3 25 | 50.4% | 37.2% | ||
| Q2 25 | 43.4% | 42.8% | ||
| Q1 25 | 42.6% | 43.1% | ||
| Q4 24 | 35.7% | 41.4% | ||
| Q3 24 | 10.5% | 43.8% | ||
| Q2 24 | 22.7% | 44.8% | ||
| Q1 24 | 17.7% | 44.0% |
营业利润率CRONFTLF
| Q4 25 | -16.8% | 8.8% | ||
| Q3 25 | -1.4% | 9.9% | ||
| Q2 25 | -15.9% | 15.6% | ||
| Q1 25 | -12.6% | 18.6% | ||
| Q4 24 | -37.5% | 19.2% | ||
| Q3 24 | -98.2% | 19.9% | ||
| Q2 24 | -56.1% | 21.7% | ||
| Q1 24 | -63.1% | 20.4% |
净利率CRONFTLF
| Q4 25 | -4.1% | 6.3% | ||
| Q3 25 | 71.4% | 3.9% | ||
| Q2 25 | -118.7% | 10.8% | ||
| Q1 25 | 19.0% | 12.7% | ||
| Q4 24 | 144.3% | 13.8% | ||
| Q3 24 | 24.4% | 13.3% | ||
| Q2 24 | -31.5% | 15.5% | ||
| Q1 24 | -8.9% | 13.1% |
每股收益（稀释后）CRONFTLF
| Q4 25 | $-0.01 | $0.16 | ||
| Q3 25 | $0.07 | $0.09 | ||
| Q2 25 | $-0.10 | $0.18 | ||
| Q1 25 | $0.02 | $0.20 | ||
| Q4 24 | $0.12 | $0.22 | ||
| Q3 24 | $0.02 | $0.21 | ||
| Q2 24 | $-0.02 | $0.27 | ||
| Q1 24 | $-0.01 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $831.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $43.6M |
| 总资产 | $1.2B | $106.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRONFTLF
| Q4 25 | $831.8M | — | ||
| Q3 25 | $824.2M | — | ||
| Q2 25 | $834.4M | — | ||
| Q1 25 | $837.8M | — | ||
| Q4 24 | $858.8M | — | ||
| Q3 24 | $862.0M | — | ||
| Q2 24 | $848.2M | — | ||
| Q1 24 | $855.1M | — |
总债务CRONFTLF
| Q4 25 | — | — | ||
| Q3 25 | — | $46.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $13.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $16.5M |
股东权益CRONFTLF
| Q4 25 | $1.1B | $43.6M | ||
| Q3 25 | $1.1B | $41.9M | ||
| Q2 25 | $1.1B | $40.9M | ||
| Q1 25 | $1.1B | $38.9M | ||
| Q4 24 | $1.1B | $36.1M | ||
| Q3 24 | $1.1B | $34.2M | ||
| Q2 24 | $1.1B | $31.9M | ||
| Q1 24 | $1.1B | $29.4M |
总资产CRONFTLF
| Q4 25 | $1.2B | $106.3M | ||
| Q3 25 | $1.2B | $110.0M | ||
| Q2 25 | $1.2B | $62.8M | ||
| Q1 25 | $1.2B | $62.2M | ||
| Q4 24 | $1.2B | $58.5M | ||
| Q3 24 | $1.2B | $58.6M | ||
| Q2 24 | $1.1B | $57.3M | ||
| Q1 24 | $1.1B | $55.5M |
负债/权益比CRONFTLF
| Q4 25 | — | — | ||
| Q3 25 | — | 1.11× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.36× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.56× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.8M | $244.0K |
| 自由现金流经营现金流 - 资本支出 | $9.7M | $239.0K |
| 自由现金流率自由现金流/营收 | 21.8% | 0.9% |
| 资本支出强度资本支出/营收 | 4.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 0.15× |
| 过去12个月自由现金流最近4个季度 | $149.0K | $7.4M |
8季度趋势，按日历期对齐
经营现金流CRONFTLF
| Q4 25 | $11.8M | $244.0K | ||
| Q3 25 | $13.3M | $3.7M | ||
| Q2 25 | $2.8M | $1.2M | ||
| Q1 25 | $-2.1M | $2.3M | ||
| Q4 24 | $7.7M | $957.0K | ||
| Q3 24 | $11.6M | $2.0M | ||
| Q2 24 | $1.7M | $1.6M | ||
| Q1 24 | $-2.2M | $5.0M |
自由现金流CRONFTLF
| Q4 25 | $9.7M | $239.0K | ||
| Q3 25 | $8.8M | $3.7M | ||
| Q2 25 | $-1.0M | $1.2M | ||
| Q1 25 | $-17.4M | $2.3M | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $5.2M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | $-3.9M | $5.0M |
自由现金流率CRONFTLF
| Q4 25 | 21.8% | 0.9% | ||
| Q3 25 | 24.3% | 15.6% | ||
| Q2 25 | -3.0% | 7.4% | ||
| Q1 25 | -53.8% | 14.5% | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -15.5% | 30.4% |
资本支出强度CRONFTLF
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 12.3% | 0.0% | ||
| Q2 25 | 11.5% | 0.0% | ||
| Q1 25 | 47.3% | 0.2% | ||
| Q4 24 | 11.7% | 0.0% | ||
| Q3 24 | 18.7% | 0.0% | ||
| Q2 24 | 2.6% | 0.0% | ||
| Q1 24 | 6.8% | 0.1% |
现金转化率CRONFTLF
| Q4 25 | — | 0.15× | ||
| Q3 25 | 0.51× | 3.99× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | -0.34× | 1.15× | ||
| Q4 24 | 0.18× | 0.46× | ||
| Q3 24 | 1.39× | 0.96× | ||
| Q2 24 | — | 0.60× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
FTLF
暂无分部数据
